The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Chimera Investment Corp

NYSE: CIM
Last

(U.S.) $13.97

Today's change-0.04 -0.29%
Updated September 1 4:08 PM EDT. Delayed by at least 15 minutes.
 

Chimera Investment Corp

NYSE: CIM
Last

(U.S.) $13.97

Today's change-0.04 -0.29%
Updated September 1 4:08 PM EDT. Delayed by at least 15 minutes.

Chimera Investment Corp crosses below 20-day moving average

Chimera Investment Corp closed lower Tuesday, dropping (U.S.)$0.04 or 0.29% to (U.S.)$13.97 and crossing below its 20-day moving average. Over the last five days, shares have gained 2.87%, but are down 12.14% for the last year to date. Shares have underperformed the S&P 500 by 11.12% during the last year.

Key company metrics

  • Open(U.S.) $13.92
  • Previous close(U.S.) $14.01
  • High(U.S.) $14.01
  • Low(U.S.) $13.85
  • Bid / Ask-- / --
  • YTD % change-12.14%
  • Volume1,865,398
  • Average volume (10-day)2,622,614
  • Average volume (1-month)2,164,092
  • Average volume (3-month)2,039,939
  • 52-week range(U.S.) $11.92 to (U.S.) $17.03
  • Beta0.80
  • Trailing P/E5.06×
  • P/E 1 year forward6.19×
  • Forward PEG1.24×
  • Indicated annual dividend(U.S.) $1.92
  • Dividend yield13.74%
  • Trailing EPS(U.S.) $2.76
Updated September 1 4:08 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+63.62%

Based on its net profit margin of 63.62%, Chimera Investment Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.72%Sector:FinancialsIndustry:Consumer Financial Services
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue216243242190
Total other revenue--------
Total revenue216243242190
Gross profit140172166142
Total cost of revenue76717648
Total operating expense100176236-187
Selling / general / administrative1911166
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)228552
Other operating expenses, total-5-1-4-26
Operating income116676378
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax116676378
Income after tax116676378
Income tax, total0000
Net income116676378
Total adjustments to net income--------
Net income before extra. items116676378
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items116676378
Inc. avail. to common incl. extra. items116676378
Diluted net income116676378
Dilution adjustment--------
Diluted weighted average shares206206206206
Diluted EPS excluding extraordinary itemsvalue per share0.570.330.031.84
Dividends per sharevalue per share0.480.480.450.45
Diluted normalized EPSvalue per share0.670.360.301.85